SIFI’s Parasitic Eye Infection Drug & Biosimilar Aflibercept Among Raft Of EU Filings

Long-Acting Injectable Aripiprazole Could Improve Schizophrenia Drug Adherence

Polyhexanide, from SIFI, could become the first approved treatment for acanthamoeba keratitis, while aflibercept could become the first biosimilar version of Eylea in the EU.

New drugs are being reviewed for potential approval in the EU • Source: Alamy

More from Europe

More from Geography